Expertise in
1
conditions

Xin X. Song

Taiyuan, CN 
Expertise in
1
conditions
Taiyuan, CN 
OverviewLocationsClinical Research

Overview

Xin Song practices in Taiyuan, China. Ms. Song is highly rated in 1 condition, according to our data. Her top areas of expertise are Lung Adenocarcinoma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer.

Her clinical research consists of co-authoring 119 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Female

Locations

Taiyuan, China
Other Locations
Yichun, 336000, China
Jilin, 132013, China
Pingxiang, 337022, China
State Key Laboratory Of Herbage Improvement And Grassland Agro Ecosystems, No. 222, South Tianshui Road, Lanzhou, 730000, China
Changsha, 410073, China
Changchun, 130012, China
Kunming, 650500, China
Qianzhou, China
Beijing, China
Xingtai, 054031, China
P.R. China, Guangzhou, 510315, China
Tianjin Key Laboratory Of Medical Epigenetics, Tianjin, 300070, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Controlled, Multi-center, Phase III Clinical Study to Investigate Recombinant Humanized PD-1 Monoclonal Antibody Injection (JS001) Versus Dacarbazine as the 1st-line Therapy for Unresectable or Metastatic Melanoma
A Randomized, Controlled, Multi-center, Phase III Clinical Study to Investigate Recombinant Humanized PD-1 Monoclonal Antibody Injection (JS001) Versus Dacarbazine as the 1st-line Therapy for Unresectable or Metastatic Melanoma
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug, Biological
Study Drugs: JS001, Dacarbazine
Study Phase: Phase 3
A Phase II, Open, Multi-center and Single Arm Study Investigating Safety and Efficacy of Recombinant Humanized Anti-PD-1 mAb for Injection in Patients With Locally Advanced or Metastatic Melanoma and Standard Treatment Failure
A Phase II, Open, Multi-center and Single Arm Study Investigating Safety and Efficacy of Recombinant Humanized Anti-PD-1 mAb for Injection in Patients With Locally Advanced or Metastatic Melanoma and Standard Treatment Failure
Enrollment Status: Unknown
Publish Date: September 30, 2020
Intervention Type: Biological
Study Drug: Humanized Anti-PD-1 Monoclonal Antibody Toripalimab
Study Phase: Phase 2
View 1 Less Clinical Trial

119 Total Publications

Harnessing Defect-Induced Electron Transfer at Pt/h-BN Interfaces for Ultra-Deep Diesel Desulfurization.
Harnessing Defect-Induced Electron Transfer at Pt/h-BN Interfaces for Ultra-Deep Diesel Desulfurization.
Journal: Inorganic chemistry
Published: November 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Song's expertise for a condition
ConditionClose
      View All 13 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile